{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T10:29:26Z","timestamp":1770719366057,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T00:00:00Z","timestamp":1294876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00277-010-1150-7","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T09:56:28Z","timestamp":1294826188000},"page":"809-818","source":"Crossref","is-referenced-by-count":103,"title":["Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab"],"prefix":"10.1007","volume":"90","author":[{"given":"W. M.","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. X.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. W.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. T.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"1150_CR1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/annonc\/mdp432","volume":"21","author":"D Villa","year":"2010","unstructured":"Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ (2010) Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol 21:1046\u20131052","journal-title":"Ann Oncol"},{"key":"1150_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","volume":"18","author":"V Boehme","year":"2007","unstructured":"Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N (2007) Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2014a survey of 1693 patients treated in protocol of German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL). Ann Oncol 18:149\u2013157","journal-title":"Ann Oncol"},{"key":"1150_CR3","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2008-10-182253","volume":"113","author":"V Boehme","year":"2009","unstructured":"Boehme V, Schmitz N, Zeynalova S, Loeffler M, Pfreundschuh M (2009) CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Blood 113:3896\u20133901","journal-title":"Blood"},{"key":"1150_CR4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12185-009-0289-2","volume":"89","author":"T Shimazu","year":"2009","unstructured":"Shimazu T, Notohara K, Ueda Y (2009) Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single centre experience. Int J Hematol 89:577\u2013583","journal-title":"Int J Hematol"},{"key":"1150_CR5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2007-07-101402","volume":"111","author":"ND Doolittle","year":"2008","unstructured":"Doolittle ND, Abrey LE, Zucca E, Shenkier TN, Tali S, Bromberg JE, Neuwelt EA, Soussain C, Johnke K, Johnston P, Illerhaus G, Schiff D, Batchelor T, Montoto S, Df K, Zucca E (2008) Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report. Blood 111:1085\u20131093","journal-title":"Blood"},{"key":"1150_CR6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","volume":"1998","author":"K Besien Van","year":"1998","unstructured":"Van Besien K, Ha CS, Murphy S, McLaughlin P, Rodriguez A, Amin K, Forman A, Romaguera J, Hagemeister F, Younes A, Bachier C, Sarris A, Sobocinski KS, Cox JD, Cabanillas F (1998) Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 1998:1178\u20131184","journal-title":"Blood"},{"key":"1150_CR7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2008.16.8021","volume":"27","author":"SH Bernstein","year":"2009","unstructured":"Bernstein SH, Unger JM, Leblanc M, Friedberg J, Miller TP, Fisher RI (2009) Natural history of CNS relapse in patients with aggressive non-Hodgkin lymphoma: a 20-year follow up analysis of SWOG 8516\u2014The Southwest Oncology Group. J Clin Oncol 27:114\u2013119","journal-title":"J Clin Oncol"},{"key":"1150_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/annonc\/mdl434","volume":"18","author":"HT Arkenau","year":"2007","unstructured":"Arkenau HT, Chong G, Cunningham D, Watkins D, Agarwal R, Sirohi B, Trumper M, Norman A, Wotherspoon A, Horwich A (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol 18:541\u2013545","journal-title":"Ann Oncol"},{"key":"1150_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"1150_CR10","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","volume":"23","author":"P Feugier","year":"2005","unstructured":"Feugier P, Van Hoof A, Sebban C et al (2005) Long term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d\u2019Etude des Lymphomes de I\u2019Adulte. J Clin Oncol 23:4117\u20134126","journal-title":"J Clin Oncol"},{"key":"1150_CR11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundshcuh","year":"2006","unstructured":"Pfreundshcuh M, Trumper L, Osterborg A et al (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379\u2013391","journal-title":"Lancet Oncol"},{"key":"1150_CR12","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","volume":"24","author":"TM Haberman","year":"2006","unstructured":"Haberman TM, Weller EA, Morrison VA et al (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121\u20133127","journal-title":"J Clin Oncol"},{"key":"1150_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","volume":"9","author":"M Pfreundshcuh","year":"2008","unstructured":"Pfreundshcuh M, Schubert Z, Ziepert M et al (2008) Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomized controlled trial (RICOVER-60). Lancet Oncol 9:105\u2013116","journal-title":"Lancet Oncol"},{"key":"1150_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.2010.01438.x","volume":"85","author":"W Yamamoto","year":"2010","unstructured":"Yamamoto W, Ishigatsubo Y et al (2010) Central nervous system involvement in diffuse large B-cell lymphoma. Eur J Hematol 85:6\u201310","journal-title":"Eur J Hematol"},{"key":"1150_CR15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","volume":"105","author":"U Hegde","year":"2005","unstructured":"Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe Es, Abati A, Stetler-Stevenson M, Wilson WH (2005) High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for CNS involvement: the role of flow cytometry versus cytology. Blood 105:496\u2013502","journal-title":"Blood"},{"key":"1150_CR16","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2003-02-0542","volume":"102","author":"H Tilly","year":"2003","unstructured":"Tilly H, Lepage E, Coiffier B, Blanc M, Herbrecht R, Bosly A, Attal M, Fillet G, Guettier C, Molina TJ, Gisselbrecht C, Reyes F (2003) Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non Hodgkin lymphoma. Blood 102:4284\u20134289","journal-title":"Blood"},{"key":"1150_CR17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1468-0734.2002.00068.x","volume":"6","author":"N Gokbuget","year":"2002","unstructured":"Gokbuget N, Hoelzer D (2002) Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol 6:114\u2013140","journal-title":"Rev Clin Exp Hematol"},{"key":"1150_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1005963732481","volume":"38","author":"N Gokbuget","year":"1998","unstructured":"Gokbuget N, Hoelzer D (1998) Meningeosis leukaemia in adult acute lymphoblastic leukaemia. J Neuro Oncol 38:167\u2013180","journal-title":"J Neuro Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1150-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-010-1150-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1150-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T23:46:25Z","timestamp":1712101585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1150-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1150-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]}}}